PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, 5290
N. diseases: 1511; N. variants: 83
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3 | 179218315 | missense variant | G/A | snv |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 10 | 2004 | 2012 | ||||||||||
|
3 | 179218315 | missense variant | G/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 8 | 2004 | 2012 | ||||||||||
|
3 | 179199003 | missense variant | C/A | snv | 4.4E-05 | 4.2E-05 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||||||
|
3 | 179218286 | missense variant | C/G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
3 | 179166120 | intron variant | T/C | snv | 7.1E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
3 | 179166549 | intron variant | C/T | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
3 | 179230408 | intron variant | A/G | snv | 1.0E-02 | 4.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
3 | 179230408 | intron variant | A/G | snv | 1.0E-02 | 4.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
3 | 179230408 | intron variant | A/G | snv | 1.0E-02 | 4.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
3 | 179199098 | missense variant | C/A | snv | 4.1E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
3 | 179199098 | missense variant | C/A | snv | 4.1E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
3 | 179169844 | intron variant | A/G | snv | 2.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms | 0.800 | 0.909 | 22 | 2006 | 2019 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.800 | 1.000 | 20 | 2006 | 2019 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 1.000 | 16 | 2006 | 2019 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.740 | 1.000 | 14 | 2004 | 2016 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 13 | 2004 | 2016 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 11 | 2004 | 2012 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms | 0.090 | 1.000 | 9 | 2012 | 2018 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms | 0.080 | 1.000 | 8 | 2012 | 2018 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.060 | 0.833 | 6 | 2012 | 2019 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.730 | 1.000 | 4 | 2008 | 2019 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.820 | 1.000 | 4 | 2005 | 2016 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.030 | 0.667 | 3 | 2013 | 2019 | |||||||
|
0.526 | 0.560 | 3 | 179234297 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.710 | 1.000 | 3 | 2005 | 2016 |